Fulgent Genetics Cash Conversion Cycle 2011-2026 | FLGT

Annual Cash Conversion Cycle Fulgent Genetics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
42.4	27.6	24.9	19.6	25.4	47	72.6	4	-40.8	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
72.6	-40.8	24.7

Quarterly Cash Conversion Cycle Fulgent Genetics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
45.8	47.2	50.2	-	32.2	29.3	35.4	-	8.29	11.5	22.9	-	33.9	40.3	16.7	13.8	12.4	67.5	23.8	10.2	72.9	659	805	31.6	20.7	31.1	61.7	52.4	50.6	53.4	41.6	10.5	-2.89	-22.7	-47	-67	-37.9	-78	-21.4	56.1	17.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
805	-78	57.6

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Biomerica BMRA	172	$ 2.13	-2.74 %	$ 4.89 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Castle Biosciences CSTL	45.9	$ 25.75	3.0 %	$ 715 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 195.6	0.17 %	$ 21.7 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	134	$ 65.94	-1.51 %	$ 25.7 B	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	42.5	$ 104.91	-	$ 19.8 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	65	$ 158.0	2.86 %	$ 7.83 B	USA
IQVIA Holdings IQV	73.9	$ 166.96	0.54 %	$ 28.7 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	166	$ 1.46	26.96 %	$ 1.86 M	USA
Interpace Biosciences IDXG	44.9	$ 1.71	0.73 %	$ 7.5 M	USA
IDEXX Laboratories IDXX	103	$ 578.51	0.22 %	$ 46.5 B	USA
Agilent Technologies A	111	$ 112.02	0.65 %	$ 34.1 B	USA
Illumina ILMN	142	$ 123.79	-0.43 %	$ 19.7 B	USA
ICON Public Limited Company ICLR	62	$ 100.35	0.65 %	$ 8.28 B	Irlanda
DarioHealth Corp. DRIO	115	$ 7.5	-6.13 %	$ 29.9 M	Israel
Guardant Health GH	79.6	$ 84.9	-0.33 %	$ 10.6 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
CareDx, Inc CDNA	51.5	$ 17.56	2.39 %	$ 936 M	USA
Lantheus Holdings LNTH	97.3	$ 75.73	-0.92 %	$ 5.11 B	USA
Medpace Holdings MEDP	50.4	$ 456.93	0.98 %	$ 13.2 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 264.42	0.54 %	$ 22 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 239.07	2.87 %	$ 25.5 B	Schweiz
Myriad Genetics MYGN	49.3	$ 4.66	1.75 %	$ 432 M	USA
ENDRA Life Sciences NDRA	-1.24 K	$ 3.48	0.87 %	$ 1.87 M	USA
NeoGenomics NEO	82.4	$ 8.1	1.76 %	$ 1.04 B	USA
National Research Corporation NRC	29.4	$ 17.51	1.1 %	$ 392 M	USA
Natera NTRA	81.5	$ 200.09	2.46 %	$ 19.7 B	USA
OPKO Health OPK	242	$ 1.15	2.68 %	$ 798 M	USA
Pacific Biosciences of California PACB	185	$ 1.39	4.51 %	$ 417 M	USA
RadNet RDNT	34.5	$ 61.74	0.41 %	$ 4.64 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA